NKG2D.ζ CAR-NK cells have been tested in clinical studies to show that they can effectively eliminate intertumoral MDSCs in neuroblastoma patients and facilitate the infiltration and efficacy of infused CAR-T cells [334]. Here, KLRK1 is linked to neuroblastoma.